CIK 0001385818 · Non-accelerated filer<br>Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 470883144
- Phone
- (720) 437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- S-1 Offering Registration Statement
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Executive or director change
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 150,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
Page 30 of 46 · 907 filings